Skip to main content
ALK-Abelló logo

ALK-Abelló — Investor Relations & Filings

Ticker · ALK ISIN · DK0061802139 LEI · 529900SGCREUZCZ7P020 CO Manufacturing
Open in API
Filings indexed 1,210 across all filing types
Latest filing 2022-08-16 Director's Dealing
Country DK Denmark
Listing CO ALK

About ALK-Abelló

https://www.alk.net

ALK-Abelló is a global, research-driven pharmaceutical company specializing in the prevention, diagnosis, and treatment of allergies. The company is a world leader in allergy immunotherapy (AIT), also known as allergy vaccination, which is a disease-modifying treatment that targets the underlying cause of the allergy rather than just the symptoms. Its portfolio includes a range of allergy treatments and services, with products such as injections, sublingual tablets, and emergency treatments for severe allergic reactions like anaphylaxis. With over a century of experience, ALK-Abelló focuses on developing pharmaceutical products to improve the quality of life for people with allergies globally.

Recent filings

Filing Released Lang Actions
Director's Dealing 2022
Director's Dealing Classification · 100% confidence The document is titled "Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff." It details specific transactions (Purchase, Sale) involving shares by individuals identified as having managerial responsibility (President & CEO, Member of the Board of Management). This content directly corresponds to the definition of Director's Dealing, which covers reports of personal share transactions by company directors and executives (insider trades). The appropriate code is DIRS.
2022-08-16 English
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
Director's Dealing Classification · 100% confidence The document is a formal notification of transactions made by company executives (Carsten Hellmann and Søren Jelert) involving ALK-Abelló A/S shares. It follows the standard regulatory format for reporting insider dealings, including details on the person with managerial responsibilities, the nature of the transaction (acquisition/disposal), price, volume, and date. This aligns perfectly with the definition of 'Director's Dealing'.
2022-08-16 Danish
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
Director's Dealing Classification · 100% confidence The document is a short announcement regarding transactions in company shares by managerial staff, citing the EU Market Abuse Regulation (MAR). It explicitly refers to an attached file containing the transaction details. Since it reports on personal share transactions by company executives, it falls under the 'Director's Dealing' category.
2022-08-16 Danish
Interim / Quarterly Report 2022
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Six-month interim report (Q2) 2022' and contains detailed financial statements, including an income statement, balance sheet, and cash flow data for the six-month period. It provides a comprehensive analysis of financial performance, strategic progress, and market trends. It is not a short announcement or a certification, but the full interim report itself. H1 2022
2022-08-11 English
Interim / Quarterly Report 2022
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Six-month interim report (Q2) 2022' and contains detailed financial statements, including an income statement, balance sheet, and cash flow data for the six-month period. It provides a comprehensive analysis of financial performance, strategic progress, and market trends. It is not a short announcement or a certification, but the full interim report itself. H1 2022
2022-08-11 English
Six-month interim report (Q2) 2022
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Six-month interim report (Q2) 2022' and contains substantive financial data, including revenue growth, EBITDA figures, and a financial outlook. Although it mentions an attached file at the end, the text itself provides a comprehensive summary of the interim financial performance, which qualifies it as an Interim/Quarterly Report (IR) rather than just an announcement (RPA). H1 2022
2022-08-11 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.